Page 4,693«..1020..4,6924,6934,6944,695..4,7004,710..»

Major leap for Aust genetic medicine

Posted: Published on January 15th, 2014

AAP A new system bought by Sydney's Garvan Institute can map the genetic makeup of 350 people a week. Australian medicine has taken a leap into the future with the purchase of a system that can quickly and cheaply map a person's genetic makeup. The new system bought by Sydney's Garvan Institute can map 350 people a week at a cost of $1000 each. This means doctors will receive quick feedback on the best way to treat cancer patients and scientists will have massive power to build an Australian genetic database. The system differs from current genetic testing in that it maps the entire genome rather than specific gene mutations such as BRCA1 and BRCA2 that cause breast and ovarian cancer. The first whole human genome was mapped more than a decade ago by an international team of scientists at a cost $1 billion. Garvan is one of a few organisations in the world to buy the HiSeq X Ten Sequencing System, according to an announcement in San Diego on Tuesday (Wednesday AEDT). "Over the next few years, we have an opportunity to learn as much about the genetics of human disease as we have learned in the history of … Continue reading

Comments Off on Major leap for Aust genetic medicine

New tool assists stem cell therapy

Posted: Published on January 15th, 2014

Published:Tuesday, January 14, 2014 Updated:Tuesday, January 14, 2014 18:01 A new tool that could help facilitate future stem cell therapy has recently been identified by a UVM professor and his colleagues, according to UVMs College of Medicine. The development of this tool could potentially help more than 700,000 Americans who suffer a heart attack each year. Because stem cells have the potential to develop into a variety of cell types in the body, they may offer a renewable source of replacement cells to treat diseases, conditions and disabilities, and even regenerate damaged tissue and organs. However, the field of regenerative medicine has struggled to successfully graft cells from culture back into injured tissue. UVM Associate Professor of Medicine Jeffrey Spees, Ph.D., collaborated with the Center for Gene Therapy at Tulane University. His research team recently set out to develop ways to enhance graft success. Dr. Spees and his team focused on a type of bone marrow-derived progenitor cell or biological cell that forms stromal cells or connective tissue cells. They found that the medium contained Connective Tissue Growth Factor (CTGF) and the hormone insulin, and together, they have a synergistic effect, Spees said to UVMs College of Medicine. The group … Continue reading

Comments Off on New tool assists stem cell therapy

Global Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019: Transparency Market Research

Posted: Published on January 15th, 2014

Albany, New York, USA (PRWEB) January 15, 2014 According to a new market report published by Transparency Market Research "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019," the market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019. Browse the full report with complete TOC at http://www.transparencymarketresearch.com/nanomedicine-market.html The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases. The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products … Continue reading

Comments Off on Global Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019: Transparency Market Research

T-cell research sheds light on why HIV can persist despite treatment

Posted: Published on January 15th, 2014

Jan. 14, 2014 Ryan Zurakowski, assistant professor of electrical and computer engineering at the University of Delaware, is co-author of a paper appearing in Nature Medicine on Jan. 12 highlighting the role of T-cells in HIV. The paper, titled "HIV-1 Persistence in CD4+ T-Cells with Stem Cell-Like Properties," provides evidence that a particular T-cell type may help researchers better understand why HIV can persist despite treatment. Zurakowski's co-authors include Mathias Lichterfeld, the paper's lead author, and researchers from Massachusetts General Hospital (MGH); Ragon Institute of MGH, the Massachusetts Institute of Technology and Harvard University; the First Affiliated Hospital of China Medical University; Brigham and Women's Hospital; and Howard Hughes Medical Institute. Zurakowski explained that HIV treatments do not kill infected cells. Instead, they stop the infection of new cells, and rely on the virus itself to kill the infected cells. Unfortunately, some cells infected by the virus -- memory T-cells -- are not killed by the virus. T-cells are a type of lymphocyte, or white blood cell, produced by the thymus gland, that actively participates in the body's immune response. "Memory" T-cells can live for years, or even decades, providing life-long immunity to previously encountered diseases. They can form "quiescent" … Continue reading

Posted in Cell Medicine | Comments Off on T-cell research sheds light on why HIV can persist despite treatment

The International Society for Stem Cell Research announces its 2014 award recipients

Posted: Published on January 15th, 2014

PUBLIC RELEASE DATE: 14-Jan-2014 Contact: Michelle Quivey mquivey@isscr.org 224-592-5012 International Society for Stem Cell Research CHICAGO The International Society for Stem Cell Research (ISSCR) has announced the following 2014 award recipients, who will be formally recognized at its 12th Annual Meeting in Vancouver, taking place June 18-21, 2014: The McEwen Award for Innovation, supported by the McEwen Centre for Regenerative Medicine, recognizes original thinking and groundbreaking research pertaining to stem cells or regenerative medicine that opens new avenues of exploration toward the understanding or treatment of human disease or affliction. The winner receives $100,000 USD. Past winners include James Thomson, Rudolf Jaenisch, Kazutoshi Takahashi and Shinya Yamanaka. Award recipient Surani is a world leader in the field of epigenetics and the development of the mammalian germ line. His work on early mammalian development led to his involvement in the discovery of genomic imprinting and ongoing contributions to understanding the mechanistic basis of imprinting. Most relevant to stem cell biology, is his work on the cellular and molecular specification of the mammalian germ cell lineage, which impacted the field's understanding of how the germ line is established and the molecular mechanisms responsible for reprogramming the epigenome in order to generate the … Continue reading

Posted in Cell Medicine | Comments Off on The International Society for Stem Cell Research announces its 2014 award recipients

Researchers identify key components linking circadian rhythms and cell division cycles

Posted: Published on January 15th, 2014

PUBLIC RELEASE DATE: 14-Jan-2014 Contact: Keith Herrell keith.herrell@uc.edu 513-558-4559 University of Cincinnati Academic Health Center CINCINNATIResearchers at the University of Cincinnati (UC) have identified key molecular components linking circadian rhythms and cell division cycles in Neurospora crassa, providing insights that could lead to improved disease treatments and drug delivery. The researchers in the UC College of Medicine Department of Molecular and Cellular Physiology, led by Christian Hong, PhD, published their findings Monday, Jan. 13, online ahead of print in PNAS (Proceedings of the National Academy of Sciences). "Our work has large implications for the general understanding of the connection between the cell cycle and the circadian clock," says Hong, an assistant professor in the molecular and cellular physiology department who collaborated with an international team of researchers on the project. The circadian rhythm, often referred to as the biological clock, is a cycle of biological activity based on a 24-hour period and generated by an internal clock synchronized to light-dark cycles and other external cues. "Everything has a schedule, and we are interested in understanding these schedules at a molecular level," Hong says. "We also wanted to know the components that connect two different oscillators (the circadian clock and cell … Continue reading

Posted in Cell Medicine | Comments Off on Researchers identify key components linking circadian rhythms and cell division cycles

Researchers identify key components linking circadian rhythms, cell division cycles

Posted: Published on January 15th, 2014

Jan. 14, 2014 Researchers at the University of Cincinnati (UC) have identified key molecular components linking circadian rhythms and cell division cycles in Neurospora crassa, providing insights that could lead to improved disease treatments and drug delivery. The researchers in the UC College of Medicine Department of Molecular and Cellular Physiology, led by Christian Hong, PhD, published their findings Monday, Jan. 13, online ahead of print in PNAS (Proceedings of the National Academy of Sciences). "Our work has large implications for the general understanding of the connection between the cell cycle and the circadian clock," says Hong, an assistant professor in the molecular and cellular physiology department who collaborated with an international team of researchers on the project. Funding for Hong's research was provided by a four-year, $3.7 million grant from the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense. He also received startup funds from UC's molecular and cellular physiology department. The circadian rhythm, often referred to as the biological clock, is a cycle of biological activity based on a 24-hour period and generated by an internal clock synchronized to light-dark cycles and other external cues. "Everything has a schedule, and we are … Continue reading

Posted in Cell Medicine | Comments Off on Researchers identify key components linking circadian rhythms, cell division cycles

Genetics of Sickle Cell Disease – Video

Posted: Published on January 15th, 2014

Genetics of Sickle Cell Disease Sickle cell disease is an inherited genetic disorder and is a recessive trait. This video describes how the genetic mutation causing sickle cell disease is p... By: Andrew Wolf … Continue reading

Posted in Genetics | Comments Off on Genetics of Sickle Cell Disease – Video

Chemistry Surface Chemistry part 3 (Adsorption Examples) CBSE class 12 XII – Video

Posted: Published on January 15th, 2014

Chemistry Surface Chemistry part 3 (Adsorption Examples) CBSE class 12 XII Chemistry Surface Chemistry part 3 (Adsorption Examples) CBSE class 12 XII. By: ExamFearVideos … Continue reading

Posted in Chemistry | Comments Off on Chemistry Surface Chemistry part 3 (Adsorption Examples) CBSE class 12 XII – Video

Stem Cells Could Prove Effective in Treating Brittle Bone Disease

Posted: Published on January 15th, 2014

Durham, NC (PRWEB) January 14, 2014 A new study released in STEM CELLS Translational Medicine indicates that stem cells can be effective in treating a debilitating and sometimes lethal genetic disorder called brittle bone disease. Brittle bone disease, or osteogenesis imperfecta (OI), is characterized by fragile bones causing some patients to suffer hundreds of fractures over the course of a lifetime. In addition, according to the OI Foundation, other symptoms include muscle weakness, hearing loss, fatigue, joint laxity, curved bones, scoliosis, brittle teeth and short stature. Restrictive pulmonary disease occurs in the more severe cases. Currently there is no cure. OI can be detected prenatally by ultrasound. In the study reported on in STEM CELLS Translational Medicine, an international team of researchers treated two patients for the disease using mesenchymal stem cells (MSCs) while the infants were still in the womb, followed by stem cell boosts after they were born. We had previously reported on the prenatal transplantation for the patient with OI type III, which is the most severe form in children who survive the neonatal period, said Cecilia Gtherstrm, Ph.D., of the Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. She and Jerry Chan, M.D., Ph.D., of the … Continue reading

Posted in Stem Cell Transplant | Comments Off on Stem Cells Could Prove Effective in Treating Brittle Bone Disease

Page 4,693«..1020..4,6924,6934,6944,695..4,7004,710..»